The NIH and the regenerative medicine field

Regenerative Medicine

Volumn 7, Issue 2, 2012, Pages 129-131

  Rao, Mahendra ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

adult stem cell; embryonic stem cell; ESC; induced pluripotent stem cell; mesenchymal stem cell; MSC; personalized therapy; regenerative medicine; regulatory standards; stem cell; translational

Indexed keywords

ADULT STEM CELL; BONE MARROW DISEASE; EDITORIAL; EMBRYONIC STEM CELL; FUNDING; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTERNATIONAL RELATIONS; LIMB ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; NATIONAL HEALTH ORGANIZATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RESOURCE ALLOCATION; STEM CELL RESEARCH;

HUMANS; INTERNATIONAL COOPERATION; NATIONAL INSTITUTES OF HEALTH (U.S.); REGENERATIVE MEDICINE; RESEARCH SUPPORT AS TOPIC; STEM CELL RESEARCH; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84858274058     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.8     Document Type: Editorial

References (5)

1. Rao MS. Funding translational work in cell-based therapy. Cell Stem Cell 9(1), 7-10 (2011).
2. Rao MS. Straight talk with. Mahendra Rao by Elie Dolgin. Nat. Med. 17(10), 1163 (2011).
3. Rao MS, Collins FS. Steering a new course for stem cell research: NIHs intramural Center for regenerative medicine. Stem Cell Trans. Med. 1, 15-17 (2012).
4. Chiu AY, Rao MS. Cell-based therapy for neural disorders - anticipating challenges. Neurotherapeutics 8(4), 744-752 (2011).
5. Rao M, Ahrlund-Richter L, Kaufman DS. Concise review: cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem Cell 30(1), 55-60 (2012).